GEM 21S® Growth-factor Enhanced Matrix was developed utilizing innovative tissue engineering principles which combine a bioactive protein (highly purified recombinant human platelet-derived growth factor, rhPDGF-BB) with an osteoconductive matrix (beta tricalcium phosphate, β-TCP).

This completely synthetic grafting system is engineered to stimulate wound healing and bone regeneration by triggering a cascade of molecular events when implanted into the body that continues on even after the implanted PDGF is gone.

GEM 21S® is currently approved for use in Israel in 3 Periodontal centers. Expansion of use will be followed by their expert experience.

 

LevPharm Ltd has signed an agreement with OssDsign to represent it in Israel and markets its products in the NeuroSurgery field  

 Lev Pharm ltd.  10 Levinson str. Petah-Tikva 49401 Israel     Tel: +972-3-9230851   Fax:  +972-3-9245074